您要查找的是不是：
- However, sirolimus stents fared better than paclitaxel stents in terms of MI, target vessel revascularization, and late thrombosis. 在心梗、靶血管的血运重建和晚期血栓文面，西罗莫司支架优于紫杉醇支架。
- By the stent, such as corbel parts and accessories. 并由支架、托臂和附件等部分组成。
- They were compared with another group of 65 patients with 65 such lesions who were treated with paclitaxel-eluting stents which used a proprietary process allowing direct paclitaxel coating. 同时与另外一组含65个用以直接紫杉醇涂层为标志的紫杉醇洗脱支架治疗新生冠脉病变的65个病人进行比较。
- Stents are small, mesh tubes that prop open narrowed arteries. 心脏支架是小的网状管道以撑开狭窄的动脉。
- Yaron Almagor Topic Bifurcation lesions: One stent or Two stents? 分叉病变几个支架更好?
- Are Drug-Eluting Stents the Perfect Choice for All CAD Patients? 药物涂层支架是所有冠心病病人的完美治疗选择吗?
- Future of Drug-eluting Coronary Stents: Do We Need Polymer? 药物洗脱支架的未来:还需要多聚物吗?
- New Generation of Stent Technology: The Polymer-free DES. 新一代支架技术:无多聚物药物洗脱支架。
- ABI increased from 0.34 to 0.81 after stent implantation. 踝 /肱指数从术前平均 0 .;3 4上升至 0
- Paclitaxel is considered one of the most promising antitumor druggery. 摘要紫杉醇是当今最有效的抗癌药物之一。
- A stent maker, Cordis, helped pay for one of the studies. 一个“药物管状物”制造商Cordis，支付了一项试验的费用。
- Objective To investigate the antiangiogenesis ability of Paclitaxel. 目的探讨紫杉醇的抗血管生成作用。
- DES in the future. Nanometer Stent? Statin-eluting Stent? 药物涂层支架的未来，纳米支架？他汀涂层支架？
- Conclusion: Paclitaxel and mitoxantone may be first-selected chemotherapeutics. 结论:推荐紫杉醇与米托蒽醌作为有效的化疗药物。
- In this article, recent progress in stent materials is reviewed. 文中回顾了最近在支架材料领域的进展。
- AIM: To develop and characterize lyophilized paclitaxel nanoemulsions. 目的:制备紫杉醇冻干纳米乳,研究其体外理化性质。
- Conclusion To apply the prostate stents in prostatic hypertrophy was safety. 结论前列腺支架治疗前列腺增生引起的排尿困难是可靠的。
- Purpose： To investigate the efficacy of the vasovasotomy without stents. 目的：探讨不用支撑物输精管吻合术的疗效。
- These issues may be aerted by biodegradable stents, the authors maintain. 作者认为生物降解支架可以防止这些问题。
- Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy. 外文期刊 Therapeutic bronchoscopy in lung cancer.
